ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.85% | 10.28% | 9.57% | 9.36% | 9.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.85% | 10.28% | 9.57% | 9.36% | 9.84% |
| Cost of Revenue | 5.37% | 2.65% | 3.01% | 3.16% | 3.12% |
| Gross Profit | 12.84% | 15.51% | 14.12% | 13.79% | 14.84% |
| SG&A Expenses | 11.81% | 11.54% | 9.72% | 8.36% | 8.06% |
| Depreciation & Amortization | -0.19% | 5.84% | 3.90% | 1.19% | -2.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.94% | 5.97% | 5.53% | 5.11% | 4.78% |
| Operating Income | 13.78% | 19.41% | 18.27% | 18.89% | 21.91% |
| Income Before Tax | 14.42% | 20.67% | 18.48% | 26.51% | 32.64% |
| Income Tax Expenses | 43.09% | 45.36% | 16.26% | 15.10% | 13.53% |
| Earnings from Continuing Operations | 8.75% | 15.71% | 18.99% | 29.21% | 37.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.75% | 15.71% | 18.99% | 29.21% | 37.20% |
| EBIT | 13.78% | 19.41% | 18.27% | 18.89% | 21.91% |
| EBITDA | 12.65% | 20.11% | 18.26% | 18.76% | 21.31% |
| EPS Basic | 9.65% | 16.40% | 19.47% | 29.56% | 37.48% |
| Normalized Basic EPS | 17.39% | 22.84% | 21.33% | 23.21% | 27.03% |
| EPS Diluted | 9.69% | 16.39% | 19.37% | 29.43% | 37.26% |
| Normalized Diluted EPS | 17.50% | 22.91% | 21.37% | 23.17% | 26.93% |
| Average Basic Shares Outstanding | -0.82% | -0.59% | -0.40% | -0.29% | -0.21% |
| Average Diluted Shares Outstanding | -0.91% | -0.64% | -0.43% | -0.25% | -0.11% |
| Dividend Per Share | 13.21% | 12.56% | 11.88% | 11.17% | 10.42% |
| Payout Ratio | 0.03% | -0.03% | -0.06% | -0.14% | -0.20% |